leadf
logo-loader
NASDAQ:IDXG

Interpace Diagnostics Group

Receive alerts
Market:
NASDAQ
Market Cap:
$12.93 m
Price
3.19 USD
Change
0.00%
52 weeks high
10.98
52 weeks low
2.58

In brief

Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests we offer are driven by rigorous, validated science.

We power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.